Low prevalence of germline BRCA1 mutations in early onset breast cancer without a family history [4]

Journal of Medical Genetics

Volumn 37, Issue 10, 2000, Pages 792-794

  Ellis, D ^a   Greenman, J ^a   Hodgson, S ^a   McCall, S ^a   Lalloo, F ^a   Cameron, J ^a   Izatt, L ^a   Scott, G ^a   Jacobs, C ^a   Watts, S ^a   Chorley, W ^a   Perrett, C ^a   Macdermot, K ^a   Mohammed, S ^a   Evans, G ^a   Mathew, C G ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA; SERINE;

ADULT; BREAST CANCER; EXON; FAMILY HISTORY; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENETIC POLYMORPHISM; GERM LINE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MUTATION; ONSET AGE; OVARY CANCER; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGE OF ONSET; BASE SEQUENCE; BREAST NEOPLASMS; CODON, TERMINATOR; DATABASES; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENE FREQUENCY; GENETIC SCREENING; GERM-LINE MUTATION; GREAT BRITAIN; HUMAN; MALE; PEDIGREE; POLYMORPHISM (GENETICS); PREVALENCE; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T; VARIATION (GENETICS);

EID: 0033785324     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (14)

1. The genetics of breast cancer susceptibility
2. Recent advances in understanding of genetic susceptibility to breast cancer
3. Mutation testing of early-onset breast cancer genes BRCA1 and BRCA2
4. The genetic attributable risk of breast and ovarian cancer
5. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence
6. Germline BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer
7. BRCA1 mutations in a population-based sample of young women with breast cancer
8. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer
9. BRCA1 mutations and breast cancer in the general population. Analyses in women before age 35 years and in women before age 45 years with first-degree family history
10. BRCA1 mutations in young women with breast cancer
11. Ultrarapid mutation detection by multiplex, solid-phase chemical cleavage
12. Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations
13. Identification of missense and truncating mutations in the BRCA1 gene in sporadic and familial breast and ovarian cancer
14. Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions